# AVEO PHARMACEUTICALS INC: Form D filings

AVEO PHARMACEUTICALS INC, a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on May 31, 2011, reports $7.5 million sold of a $7.5 million offering to 1 investor.

Find out what AVEO PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AVEO%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AVEO%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Faveo-pharmaceuticals-inc-1325879)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AVEO%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AVEO%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Faveo-pharmaceuticals-inc-1325879)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 75 SIDNEY STREET, 4TH FLOOR, Cambridge, MA, 02139
- Phone: (617) 299-5000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1325879

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 31, 2011 | New notice | $7,499,997 | $7,499,997 | $0 | 1 | May 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1325879/000132587911000001/0001325879-11-000001-index.htm) |
| Nov 3, 2010 | New notice | $60,750,000 | $60,750,000 | $0 | 21 | Nov 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1325879/000132587910000003/0001325879-10-000003-index.htm) |
| Apr 1, 2009 | New notice | $60,000,000 | $30,000,000 | $30,000,000 | 1 | Mar 18, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1325879/000132587909000003/0001325879-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kenneth M. Bate | Director |  |
| Nicholas Galakatos | Director |  |
| Jeno Gyuris | Executive Officer |  |
| Henri A. Termeer | Director |  |
| Kenneth C. Weg | Director |  |
| Ronald DePinho | Director |  |
| Michael A. Bailey | Executive Officer |  |
| William M. Slichenmyer | Executive Officer |  |
| Douglas Cole | Director |  |
| Raju C. Kucherlapati | Director |  |
| David Johnston | Executive Officer |  |
| Tuan Ha-Ngoc | Executive Officer, Director |  |
| Elan M. Ezickson | Executive Officer |  |
| Robert C. Young | Director |  |
| Russell C. Hirsch | Director |  |
| Anthony Evnin | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of May 30, 2011](https://specstream.ai/data/form-d/week/2011-05-30) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what AVEO PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).